Actively Recruiting
Developing and Testing Health Warning Labels on the ENDS Device
Led by Florida International University · Updated on 2026-04-03
80
Participants Needed
1
Research Sites
176 weeks
Total Duration
On this page
Sponsors
F
Florida International University
Lead Sponsor
U
University of Miami
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.
CONDITIONS
Official Title
Developing and Testing Health Warning Labels on the ENDS Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Generally healthy individuals as determined by physical examination
- Age between 21 and 35 years
- Willing to provide informed consent
- Willing to attend lab visits as required by the study
- Current ENDS users, either daily or occasionally in the past 30 days
- Have abstained from ENDS use for at least 12 hours prior to each study session
You will not qualify if you...
- Regular cigarette smokers (more than 5 cigarettes per month in the past year)
- Regular users of any other tobacco or nicotine products in the past year
- Women who are breastfeeding or test positive for pregnancy
- Individuals with a history of chronic disease or psychiatric conditions
- Individuals with a history of or active cardiovascular disease, abnormal blood pressure, seizures, or those regularly using prescription medications (other than vitamins or birth control)
- Use of non-commercial or street e-cigarette liquids or products
- Current symptoms related to EVALI or COVID-19 such as cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhea, fever, chills, or weight loss
- Exposure to COVID-19 within the last 14 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Florida International University
Miami, Florida, United States, 33199
Actively Recruiting
Research Team
W
Wasim Maziak, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here